MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): Technical aspects and findings in patients affected by Crohn's disease;Risonanza magnetica del piccolo intestino con mezzo di contrasto orale bifasico (polietilenglicole, PEG): Aspetti tecnici e risultati in una popolazione di pazienti con morbo di Crohn

Radiologia Medica

Volumn 106, Issue 1-2, 2003, Pages 18-27

  Laghi, Andrea ^a   Paolantonio, Pasquale ^a   Iafrate, Franco ^a   Borrelli, Osvaldo ^a   Dito, Lucia ^a   Tomei, Ernesto ^a   Cucchiara, Salvatore ^a   Passariello, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

MR, oral contrast agent; MR, small bowel; Small bowel, Crohn's disease

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; MACROGOL; SCOPOLAMINE BUTYL BROMIDE; SELG;

ABDOMINAL ABSCESS; ADIPOSE TISSUE; ADOLESCENT; ADULT; ARTICLE; BREATH HOLDING; CECUM; CHILD; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CROHN DISEASE; DISEASE ACTIVITY; DRUG TOLERABILITY; FEMALE; FOURIER TRANSFORMATION; HUMAN; ILEUM; IMAGING SYSTEM; INFLAMMATION; INTESTINE STENOSIS; LYMPHADENOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICS; REPRODUCIBILITY; SIDE EFFECT; SMALL INTESTINE; TECHNOLOGY; THREE DIMENSIONAL IMAGING; VOLUMETRY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; CROHN DISEASE; FEMALE; HUMANS; INTESTINE, SMALL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS;

EID: 0141989921     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Maglinte DD, Siegelman ES, Kelvin FM. MR enteroclysis: the future of small-bowel imaging? Radiology 215: 639-641, 2000.
2. Ha HK, Lee EH, Lim CH et al: Application of MRI for small intestinal diseases. J Magn Reson Imaging 8: 375-883, 1998.
3. Schreyer AG, Herfarth H, Kikinis R et al: 3D modeling and virtual endoscopy of the small bowel based on magnetic resonance imaging in patients with inflammatory bowel disease. Invest Radiol 37: 528-533, 2002.
4. Laghi A, Paolantonio P, Iafrate F et al: Oral contrast agent for magnetic resonance imaging of the bowel. Top Magn Reson Imaging 13: 389-396, 2002.
5. Laghi A, Carbone I, Catalano C et al: Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. Am J Roentgenol 177: 1333-1334, 2001.
6. Laghi A, Paolantonio P, Catalano C, et al: MR imaging of the small bowel using polyethylene glycol as an oral contrast agent in adults and children with celiac disease: preliminary observations. Am J Roentgenol 180: 191-194, 200.
7. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al: MR enteroclysis: technical considerations and clinical applications. Eur Radiol 12: 2651-2682, 2002.
8. Pallotta N, Baccini F, Corazzieri E: Ultrasonography of the small bowel oral administration of anechoic contrast solution. Lancet 353: 985-986, 1999.
9. Rohr A, Rohr D, Kuhbacher T el al: Radiological assessment of small bowel obstructions: Value of conventional enteroclysis and dynamic MR-enteroclysis. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 174: 1158-1164, 2002.
10. Albert J, Scheidt T, Basler B et al: Magnetic Resonance Imaging in diagnosis and follow-up of Crohn's Disease-Is conventional enteroclysis still necessary? Gastroenterol 40: 789-794, 2002.
11. Rieber A, Nussle K, Reinshagen M, et al: MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom Imaging 27: 394-349, 2002.
12. Patak MA, Froehlich JM, von Weymarn C et al: Non-invasive distension of the small bowel for magnetic-resonance imaging. Lancet 358: 987-988, 2001.
13. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al: MR imaging of the small bowel with a true-FISP sequence after enteroclysis with water solution. Invest Radiol 35: 707-711, 2000.
14. Malcolm PN, Brown JJ, Hahn PF et al: The clinical value of ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen. J Magn Reson Imaging 12: 702-707, 2000.
15. Rieber A, Aschoff A, Nussle K et al: MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 10: 1377-1382, 2000.
16. Maccioni F, Viscido A, Broglia L et al: Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25: 219-28, 2000.
17. Sood RR, Jobert I, Franklin H et al: Small bowel MRI: Comparison a polyethylene glycol preparation and water as oral contrast media. J Magn Reson Imaging 15: 401-408, 2002.
18. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al: MR enteroclysis protocol optimization: comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences. Eur Radiol 11: 908-913, 2001.
19. Marcos HB, Semelka RC: Evaluation of Crohn's disease using half-Fourier RARE and gadolinium-enhanced SGE sequences: initial results. Magn Reson Imaging 18: 263-268, 2000.
20. Lomas DJ, Graves MJ: Small bowel MRI using water as a contrast medium. Br J Radiol 862: 994-997, 1999.
21. Minowa O, Ozaki Y, Kyogoku S et al: MR imaging of the small bowel using water as a contrast agent in a preliminary study with healthy volunteers. Am J Roentgenol 173: 581-582, 1999.
22. Grubnic S, Padhani AR, Revell PB et al: Comparative efficacy of and sequence choice for two oral contrast agents used during MR imaging. Am J Roentgenol 173: 173-178, 1999.
23. Debatin JF, Patak MA: MRI of the small and large bowel. Eur Radiol 9: 1523-1534, 1999.
24. Adamek HE, Breer H, Karschkes T, et al: Magnetic resonance imaging in gastroenterology: time to say good-bye to all that endoscopy? Endoscopy 32: 406-410, 2000.
25. Rieber A, Wruk D, Potthast S et al: Diagnostic imaging in Crohn's disease: comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis 15: 176-181, 2000.